Green tea leaf constituents inhibit the formation of lysozyme amyloid aggregates: An effect of mutual interactions.
Autor: | Gancar M; Institute of Experimental Physics Slovak Academy of Sciences, Watsonova 47, 040 01, Kosice, Slovakia., Kurin E; Faculty of Pharmacy, Comenius University Bratislava, Odbojarov 10, 832 32 Bratislava, Slovakia. Electronic address: elena.kurin@uniba.sk., Bednarikova Z; Institute of Experimental Physics Slovak Academy of Sciences, Watsonova 47, 040 01, Kosice, Slovakia., Marek J; Institute of Experimental Physics Slovak Academy of Sciences, Watsonova 47, 040 01, Kosice, Slovakia., Mucaji P; Faculty of Pharmacy, Comenius University Bratislava, Odbojarov 10, 832 32 Bratislava, Slovakia., Nagy M; Faculty of Pharmacy, Comenius University Bratislava, Odbojarov 10, 832 32 Bratislava, Slovakia., Gazova Z; Institute of Experimental Physics Slovak Academy of Sciences, Watsonova 47, 040 01, Kosice, Slovakia. Electronic address: gazova@saske.sk. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of biological macromolecules [Int J Biol Macromol] 2023 Jul 01; Vol. 242 (Pt 2), pp. 124856. Date of Electronic Publication: 2023 May 12. |
DOI: | 10.1016/j.ijbiomac.2023.124856 |
Abstrakt: | Amyloidoses represent a group of pathological conditions characterized by amyloid fibrils accumulating in the form of deposits in intra- or extracellular space, leading to tissue damage. The lysozyme from hen egg-white (HEWL) is often used as a universal model protein to study the anti-amyloid effects of small molecules. The in vitro anti-amyloid activity and mutual interactions of green tea leaf constituents: (-)-epigallocatechin gallate (EGCG), (-)-epicatechin (EC), gallic acid (GA), caffeine (CF) and their equimolar mixtures were studied. The inhibition of HEWL amyloid aggregation was monitored by a Thioflavin T fluorescence assay and atomic force microscopy (AFM). The interactions of the analyzed molecules with HEWL were interpreted by ATR-FTIR and protein-small ligand docking studies. EGCG was the only substance efficiently inhibiting amyloid formation (IC Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |